Valent BioSciences Launches New Biostimulant Operating Unit


LIBERTYVILLE, Illinois, October 12, 2022 – Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1. The new operating unit was established in February 2022 and it is now fully operational, enabling the organization to serve the entire U.S market. This transition marks a major change in the go-to-market strategy for Valent BioSciences, as the company begins selling biostimulant products directly to U.S. channel partners.

The new biostimulant business team and salesforce are focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability.

“As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,” said Salman Mir, Executive Vice President and Chief Operating Officer at Valent BioSciences. “Biostimulant products, including our AMF technologies, also support the mission of our parent company, Sumitomo Chemical Co., Ltd., for achieving carbon neutrality by 2050, as well as its global goal of attaining carbon neutrality for society as a whole.”

The core Valent BioSciences biostimulant products are being marketed under the SymvadoTM and ProliantTM brand names. The team is focused on achieving customer success with biostimulants and will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market.

“We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,” said Dave Schumacher, Vice President of Commercial Operations for Valent BioSciences.

The new biostimulants business at Valent BioSciences includes numerous technical experts who are available to help retailers and growers navigate this complex market segment.

“We have more than 60 years of broad biorational crop enhancement expertise, and this launch incorporates the next generation of tools to help our customers succeed,” said Mir. “We are in an excellent position to lead the biostimulants industry as it transitions to science-driven biostimulant products that positively impact the bottom line.”

For more information about Valent BioSciences biostimulant products, please call 877-696-4204 or email


About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at

Media Contact:

John Mandel
Valent BioSciences LLC

Download Press Release


Related News

WHITE CITY, Ore., September 21, 2023 – To meet the increasing demands and...
Broadening its commitment to sustainability and corporate social value, Valent BioSciences LLC formally dedicated a new prairie park and solar field adjacent to its manufacturing facility in Osage, Iowa, on June 24.
The Pest Management Regulatory Agency (PMRA) recently approved, for the first time, drone use as an application method for three Public Health products from Valent BioSciences LLC.
Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.
Valent BioSciences LLC announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions.
The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational.